logo
episode-header-image
Oct 2025
4m 25s

Kering Up, Holcim Gains, TKMS Rises

iHeartPodcasts
About this episode

On this episode of Stock Movers:
- Kering agreed to sell its beauty division to L’Oreal SA as part of a long-term strategic alliance, its stock having risen about 36% since the start of the year.
_ Holcim is set to acquire Xella, a European walling systems company, in a €1.85 billion ($2.2 billion) deal expanding its building solutions business following the spin off of its North American unit.
- TKMS, Germany's largest warship-maker and the spin-off of defence group Thyssenkrupp, rose as high as €75 a share up from €60 in the first minutes of its trading debut.

See omnystudio.com/listener for privacy information.

Up next
Yesterday
Week Ahead: Carnival, FedEx & Darden Restaurants
Today's biggest winners and losers in the stock market.Carnival, FedEx and Darden Restaurants are in focus. Bloomberg’s Nathan Hager previews what to expect from these companies in the week ahead with Avalon Pernell, Bloomberg News reporter.See omnystudio.com/listener for privacy ... Show More
5m 57s
Jun 19
ASML Down, Novo Rises, Nexans Gains
Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Dutch chip-equipment giant ASML is contending with its biggest challenge yet under the Trump administration: In a series of recent meetings, Commerce Secretary Howard Lutnick outlined concern ... Show More
4m 57s
Jun 19
ASML Dips, Novo Jumps, Vestas Gains
Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Dutch chip-equipment giant ASML is contending with its biggest challenge yet under the Trump administration: In a series of recent meetings, Commerce Secretary Howard Lutnick outlined concern ... Show More
5m 13s
Recommended Episodes
Jun 2025
Nvidia Closes In On a $4 Trillion Market Value
Bloomberg’s Ed Ludlow discusses the prospects of Nvidia becoming the first company to reach a $4 trillion market capitalization. Plus, US Commerce Secretary Howard Lutnick says the US and China have reached an understanding on a trade deal. And data center builder Crusoe announce ... Show More
39m 7s
Oct 2024
Morgan Stanley’s Big Beat, Amazon Goes Nuclear, Luxury Letdown 10/16/24
<p>Carl Quintanilla, Jim Cramer and David Faber started the show by breaking down the quarterly results out of Morgan Stanley. Shares of the big bank soared to new record highs, after topping estimates on better-than-expected wealth management, trading and banking results. A simi ... Show More
42m 4s
Oct 2025
OpenAI Becomes World’s Largest Startup
Bloomberg’s Caroline Hyde and Ed Ludlow discuss OpenAI becoming the largest startup after it closed a deal allowing current and former employees to sell shares at a $500 billion valuation. Plus, Tesla's vehicle sales jumped to a worldwide record in the third quarter as US buyers ... Show More
42m 57s
Oct 2023
⚡🧃 “The energy drink stock up 4,000%” — Celsius’ lucky surge. Barbie & Ken’s GDP surprise. Ford’s negotiation lesson.
The #1 stock on Wall Street? It’s Celsius Energy Drink, up 4,000% in the last 5 years — But this overnight success was actually 20 years in the making.Barbie powered Mattel to great earnings and America’s GDP soared 4.9% higher this summer — But stocks are falling because investo ... Show More
19m 55s
Jul 2025
Fed Holds and Big Tech Beats; US-South Korea Trade Deal
US equity-index futures climbed as strong earnings from megacap tech firms bolstered optimism that corporate profits remain resilient. The dollar steadied after gaining on Federal Reserve holding interest rates. Contracts for the Nasdaq 100 rose 1.2% and those for the S&P 500 adv ... Show More
20m 24s
Aug 2025
OpenAI Staffers to Sell $6 Billion Worth of Shares
Bloomberg’s Matt Miller discusses plans by current and former OpenAI employees to sell $6 billion worth of shares to an investor group that includes SoftBank. Plus, investors react to US government plans to take a stake in Intel. And global competition in the electric vehicle spa ... Show More
43m 41s
Jul 2025
ICYMI: AstraZeneca Profit, Revenue Lifted by Cancer Drugs
AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the US.Revenue climbed 12% to $14.5 billion, the UK drugmaker said Tuesday, beating estimates. Earnings per share excluding some i ... Show More
14m 39s
Sep 2025
Markets hold firm as shutdown fears loom
European markets closed higher yesterday, buoyed by strong performances in the healthcare and luxury sectors. In the US, concerns over a potential government shutdown failed to dampen investor sentiment, as a rebound in AI-related stocks helped support equity markets. Beyond mark ... Show More
13m 11s
Sep 2024
Much to absorb in this data-heavy week
<p>Investors are grappling with a flood of data this week. Yesterday’s releases from the US revealed a two-year high in the trade deficit, a slowdown in the labour market and a cautious outlook from the Fed’s Beige Book. However, there was some respite as US factory orders reboun ... Show More
15m 58s